PREDNISOLONE TEBUTATE Drug Patent Profile
✉ Email this page to a colleague
When do Prednisolone Tebutate patents expire, and when can generic versions of Prednisolone Tebutate launch?
Prednisolone Tebutate is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in PREDNISOLONE TEBUTATE is prednisolone tebutate. There are eighty-eight drug master file entries for this compound. Additional details are available on the prednisolone tebutate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PREDNISOLONE TEBUTATE?
- What are the global sales for PREDNISOLONE TEBUTATE?
- What is Average Wholesale Price for PREDNISOLONE TEBUTATE?
Summary for PREDNISOLONE TEBUTATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Patent Applications: | 2,097 |
| DailyMed Link: | PREDNISOLONE TEBUTATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PREDNISOLONE TEBUTATE
US Patents and Regulatory Information for PREDNISOLONE TEBUTATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | PREDNISOLONE TEBUTATE | prednisolone tebutate | INJECTABLE;INJECTION | 083362-001 | Feb 17, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
